Scientists at University Of Pittsburgh May Have Invented a Vaccine for Coronavirus

  • Scientists at University Of Pittsburgh May Have Invented a Vaccine for Coronavirus

Scientists at University Of Pittsburgh May Have Invented a Vaccine for Coronavirus

It should be noted that a vaccine for the Novel Coronavirus will need to be put through especially stringent safety testing to rule out the risk of enhanced disease. The animal tests of the new vaccine, which is about the size of the fingertip, have been successful.

"Bharat Biotech in Hyderabad will then begin production scale-up for safety and efficacy testing in humans".

"Pandemics for coronaviruses have become a new normal".

The researchers emphasise that the SARS-CoV-2 microneedle vaccine maintains its potency even after being thoroughly sterilised with gamma radiation - a key step toward making a product that's suitable for use in humans. Tests and reviews are ongoing to get the long-term results of these vaccines.

In a news release, the researchers said that the vaccine would be "highly scalable" for general use.

Scientists at the University of Pittsburgh, where Jonas Salk developed the polio vaccine, used the school's 2003 research into SARS-CoV to come up with a COVID-19 vaccine that is showing promise.

A research team at the University of Pittsburgh School of Medicine has said that they have moved quickly in developing a potential vaccine for coronavirus which causes Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). That virus and SARS-CoV were related to COVID-19 in that a protein called a spike protein was important for causing immunity against the coronavirus.

The patch is applied much like a stick-on bandage with the needles dissolving into the skin. While there is an experimental mRNA COVID-19 vaccine candidate under investigation, the vaccine described in EBioMedicine uses laboratory developed pieces of viral protein to induce immunity.

The vaccine is delivered through a novel approach, known as a microneedle array.

The patch contains 400 tiny "microneedles" made of sugar and protein pieces.

The new coronavirus vaccine, which works with the system called micro needle array, can also be scaled at high rates. Once manufactured, the vaccine can sit at room temperature until it's needed and does not require a needle for administration.

Although the mice haven't been monitored long run, the researchers mentioned mice in vaccine trials for MERS-CoV "produced an adequate level of antibodies to neutralize the virus for no less than a 12 months" and indicated the antibody ranges within the mice aside of the brand new research "appear to be following the identical development". However, the animals have not been followed for a long time yet.

The researchers were able to act quickly due to experience with working during earlier coronavirus epidemics.

"We'll first make the vaccine for human clinical studies in multiple countries", said Raches Ella, Bharat's head of business development.